Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Clark

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.
The American Journal of Surgical Pathology|July 15, 2004
Metastatic juxtaglomerular cell tumor in a 52-year-old manXiuzhen Duan, Patrick Bruneval, Rasheed Hammadeh, et al.
American Journal of Clinical Oncology|June 3, 2009
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312Peter J Van Veldhuizen, Michael Hussey, Primo N Lara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019Kathy S Albain, John J Crowley, Andrew T Turrisi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelMartin J Edelman, Joseph I Clark, Kari Chansky, et al.
Neurosurgery|April 8, 2009
Clinicopathological review: esthesioneuroblastomaTaryn McFadden Bragg, Joseph Scianna, Amin Kassam, et al.
American Journal of Clinical Oncology|May 6, 2009
Phase I adjuvant radiation with docetaxel in high-risk head and neck cancerJoseph I Clark, Robert M Eisner, Craig Hofmeister, et al.
Cancer|September 16, 2008
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group studyMichael B Atkins, Jeffrey A Sosman, Sanjiv Agarwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317Michael S Gordon, Michael Hussey, Raymond B Nagle, et al.
Cancer|November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508Joseph I Clark, James Moon, Laura F Hutchins, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.
The American Journal of Surgical Pathology|July 15, 2004
Metastatic juxtaglomerular cell tumor in a 52-year-old manXiuzhen Duan, Patrick Bruneval, Rasheed Hammadeh, et al.
American Journal of Clinical Oncology|June 3, 2009
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312Peter J Van Veldhuizen, Michael Hussey, Primo N Lara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019Kathy S Albain, John J Crowley, Andrew T Turrisi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelMartin J Edelman, Joseph I Clark, Kari Chansky, et al.
Neurosurgery|April 8, 2009
Clinicopathological review: esthesioneuroblastomaTaryn McFadden Bragg, Joseph Scianna, Amin Kassam, et al.
American Journal of Clinical Oncology|May 6, 2009
Phase I adjuvant radiation with docetaxel in high-risk head and neck cancerJoseph I Clark, Robert M Eisner, Craig Hofmeister, et al.
Cancer|September 16, 2008
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group studyMichael B Atkins, Jeffrey A Sosman, Sanjiv Agarwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317Michael S Gordon, Michael Hussey, Raymond B Nagle, et al.
Cancer|November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508Joseph I Clark, James Moon, Laura F Hutchins, et al.
Pageof 7